Uwe G. Liebert

7.2k total citations
163 papers, 4.1k citations indexed

About

Uwe G. Liebert is a scholar working on Epidemiology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Uwe G. Liebert has authored 163 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Epidemiology, 72 papers in Infectious Diseases and 33 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Uwe G. Liebert's work include Virology and Viral Diseases (48 papers), Viral Infections and Immunology Research (33 papers) and Respiratory viral infections research (27 papers). Uwe G. Liebert is often cited by papers focused on Virology and Viral Diseases (48 papers), Viral Infections and Immunology Research (33 papers) and Respiratory viral infections research (27 papers). Uwe G. Liebert collaborates with scholars based in Germany, Ethiopia and United States. Uwe G. Liebert's co-authors include Volker ter Meulen, Corinna Pietsch, K. Baczko, Ute Brinckmann, Melanie Maier, Claudia Claus, Daniela Finke, Andargachew Mulu, Herbert Budka and S Schneider-Schaulies and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and ACS Nano.

In The Last Decade

Uwe G. Liebert

161 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uwe G. Liebert Germany 38 2.2k 1.6k 730 689 563 163 4.1k
Tetsushi Yoshikawa Japan 45 5.0k 2.3× 2.6k 1.6× 549 0.8× 453 0.7× 515 0.9× 326 7.1k
Elisabeth Puchhammer‐Stöckl Austria 36 1.8k 0.8× 1.4k 0.9× 360 0.5× 400 0.6× 252 0.4× 136 3.6k
Aloys C.M. Kroes Netherlands 38 2.9k 1.3× 2.0k 1.2× 440 0.6× 339 0.5× 352 0.6× 153 4.5k
Anna Maria Eis‐Hübinger Germany 35 1.4k 0.6× 1.6k 1.0× 319 0.4× 572 0.8× 389 0.7× 102 3.5k
Roxann Ingersoll United States 25 862 0.4× 1.5k 0.9× 465 0.6× 364 0.5× 1.1k 2.0× 41 5.2k
Mauro Pistello Italy 44 2.4k 1.1× 1.7k 1.1× 693 0.9× 588 0.9× 921 1.6× 233 6.0k
Nicole Fischer Germany 36 713 0.3× 782 0.5× 336 0.5× 423 0.6× 938 1.7× 118 3.6k
Alan Heath United Kingdom 33 1.6k 0.7× 994 0.6× 220 0.3× 304 0.4× 433 0.8× 123 3.4k
Jörg Hofmann Germany 36 1.6k 0.7× 2.9k 1.8× 230 0.3× 895 1.3× 1.0k 1.8× 162 6.4k
Richard R. Spaete United States 34 3.5k 1.6× 1.1k 0.7× 234 0.3× 502 0.7× 592 1.1× 41 4.0k

Countries citing papers authored by Uwe G. Liebert

Since Specialization
Citations

This map shows the geographic impact of Uwe G. Liebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe G. Liebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe G. Liebert more than expected).

Fields of papers citing papers by Uwe G. Liebert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe G. Liebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe G. Liebert. The network helps show where Uwe G. Liebert may publish in the future.

Co-authorship network of co-authors of Uwe G. Liebert

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe G. Liebert. A scholar is included among the top collaborators of Uwe G. Liebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe G. Liebert. Uwe G. Liebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schulze, Agnes, et al.. (2022). Photodynamic Inactivation of SARS-CoV-2 Infectivity and Antiviral Treatment Effects In Vitro. Viruses. 14(6). 1301–1301. 12 indexed citations
3.
Dagnew, Mulat, Feleke Moges, Moges Tiruneh, et al.. (2022). Molecular diversity of hepatitis B virus among pregnant women in Amhara National Regional State, Ethiopia. PLoS ONE. 17(11). e0276687–e0276687. 3 indexed citations
4.
Hönemann, Mario, Christian Lück, Melanie Maier, et al.. (2021). Comprehensive evaluation of eight commercial SARS-CoV-2 IgG assays. Diagnostic Microbiology and Infectious Disease. 100(4). 115382–115382. 3 indexed citations
5.
Hönemann, Mario, et al.. (2021). Human Rhinoviruses in Adult Patients in a Tertiary Care Hospital in Germany: Molecular Epidemiology and Clinical Significance. Viruses. 13(10). 2027–2027. 13 indexed citations
6.
Eis‐Hübinger, Anna Maria, Mario Hönemann, Jürgen J. Wenzel, et al.. (2020). Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples. Journal of Clinical Virology. 127. 104381–104381. 34 indexed citations
7.
McIlroy, Dorian, Mario Hönemann, Paul Barbier, et al.. (2020). Persistent BK Polyomavirus Viruria Is Associated with Accumulation of VP1 Mutations and Neutralization Escape. Viruses. 12(8). 824–824. 16 indexed citations
8.
Pietsch, Corinna, Dominik Michalski, Sirak Petros, et al.. (2020). Autochthonous West Nile virus infection outbreak in humans, Leipzig, Germany, August to September 2020. Eurosurveillance. 25(46). 35 indexed citations
9.
Hönemann, Mario, David H. Martin, Corinna Pietsch, et al.. (2019). Influenza B virus infections in Western Saxony, Germany in three consecutive seasons between 2015 and 2018: Analysis of molecular and clinical features. Vaccine. 37(43). 6550–6557. 7 indexed citations
10.
Gelaw, Aschalew, Corinna Pietsch, & Uwe G. Liebert. (2018). Molecular epidemiology of rotaviruses in Northwest Ethiopia after national vaccine introduction. Infection Genetics and Evolution. 65. 300–307. 16 indexed citations
11.
Pietsch, Corinna & Uwe G. Liebert. (2018). Rotavirus vaccine effectiveness in preventing hospitalizations due to gastroenteritis: a descriptive epidemiological study from Germany. Clinical Microbiology and Infection. 25(1). 102–106. 22 indexed citations
12.
Schmidt, Tobias, Angelika Schierhorn, Hauke Lilie, et al.. (2016). Arginine methylation enhances the RNA chaperone activity of the West Nile virus host factor AUF1 p45. RNA. 22(10). 1574–1591. 19 indexed citations
13.
Gonzalez, Mark D., Blake W. Buchan, Matthew L. Faron, et al.. (2015). Multicenter Evaluation of the Xpert Norovirus Assay for Detection of Norovirus Genogroups I and II in Fecal Specimens. Journal of Clinical Microbiology. 54(1). 142–147. 31 indexed citations
14.
Mulu, Andargachew, Melanie Maier, & Uwe G. Liebert. (2013). Deworming of intestinal helminths reduces HIV-1 subtype C viremia in chronically co-infected individuals. International Journal of Infectious Diseases. 17(10). e897–e901. 23 indexed citations
15.
Frank, Hugh A., et al.. (2010). Lethal influenza B myocarditis in a child and review of the literature for pediatric age groups. Infection. 38(3). 231–235. 25 indexed citations
16.
Kamprad, Manja, et al.. (2009). Determination of rubella virus‐specific cell‐mediated immunity using IFNγ‐ELISpot. Journal of Medical Virology. 82(2). 335–340. 7 indexed citations
17.
Kaiser, Thorsten, Uwe G. Liebert, Alexander Leichtle, et al.. (2008). Prevalence, Aetiology and Associated Co-Morbidities of Elevated Aminotransferases in a German Cohort of Orthopaedic Surgery Patients. Zeitschrift für Gastroenterologie. 46(5). 415–420. 12 indexed citations
18.
Claus, Claudia, Wen‐Pin Tzeng, Uwe G. Liebert, & Teryl K. Frey. (2007). Analysis of the selective advantage conferred by a C-E1 fusion protein synthesized by rubella virus DI RNAs. Virology. 369(1). 19–34. 3 indexed citations
19.
Wiedmann, Marcus, Uwe G. Liebert, U. Oesen, et al.. (2000). Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology. 31(1). 230–234. 131 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsushi Yoshikawa Breakdown of academic impact, for papers by Elisabeth Puchhammer‐Stöckl Breakdown of academic impact, for papers by Aloys C.M. Kroes Breakdown of academic impact, for papers by Anna Maria Eis‐Hübinger Breakdown of academic impact, for papers by Roxann Ingersoll Breakdown of academic impact, for papers by Mauro Pistello Breakdown of academic impact, for papers by Nicole Fischer Breakdown of academic impact, for papers by Alan Heath Breakdown of academic impact, for papers by Jörg Hofmann Breakdown of academic impact, for papers by Richard R. Spaete
Rankless by CCL
2026